Inhibitors that prevent activin receptor IIB activation and myostatin-binding proteins (e.g., follistatin) fall under WADA's expanded interpretation
Cons: Vary in absorption and efficiency, potentially longer periods to observe health benefits, no skin-lightening effect, and requires consistent long-term use to maintain levels
Regulatory Status AOD-9604 is not an FDA-approved drug for any indication and has not been shown to be safe or effective for any human use
According to the Mayo Clinic, if your vitamin deficiency is severe enough to make you feel lethargic, you could gain weight as a result of reducing your exercise and movement
The mechanism here overlaps with the tendon application: BPC-157 improves local blood supply and growth factor signaling at the repair site, shortening the window between injury and return to full loading
Certain ALOX inhibitors (e.g., baicalein) protect cells against lipid peroxidation and ferroptosis [104]